Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,988
Total Claims
$3.2M
Drug Cost
808
Beneficiaries
$4,001
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+241%
Cost per patient vs peers
$4,001 vs $1,174 avg
+206%
Brand preference vs peers
27.2% vs 8.9% avg
Brand vs Generic
Brand: 4,560 claims · $2.7M
Generic: 12,231 claims · $506K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 1,347 | $600K |
| Diclofenac Epolamine | 753 | $548K |
| Tenofovir Alafenamide | 144 | $215K |
| Lipase/Protease/Amylase | 174 | $200K |
| Cyclosporine | 182 | $168K |
| Metformin Hcl | 62 | $151K |
| Empagliflozin | 135 | $112K |
| Semaglutide | 70 | $80K |
| Sitagliptin Phosphate | 93 | $70K |
| Dapagliflozin Propanediol | 103 | $68K |
| Sitagliptin Phos/Metformin Hcl | 106 | $66K |
| Rivaroxaban | 81 | $56K |
| Mometasone Furoate | 441 | $51K |
| Linaclotide | 74 | $47K |
| Bepotastine Besilate | 183 | $43K |
Prescribing Profile
Patient Profile
72
Avg Age
48%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data